Compare Fortive Corporation Common Stock (FTV) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fortive Corporation Common Stock vs Immunovant Inc. Common Stock — how do they compare? Fortive Corporation Common Stock trades at $56.51 (market cap $17.07B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Fortive Corporation Common Stock is far larger — about 2.6× Immunovant Inc. Common Stock's market cap, and Fortive Corporation Common Stock pays a 0.5% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fortive Corporation Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| FTV | IMVT | |
|---|---|---|
Market Cap | $17.07B | $6.62B |
Volume | 1,773,097 | 1,131,364 |
Sector | Technology | Health |
52-Week High | $64.09 | $44.96 |
52-Week Low | $47.80 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $20.21B | $5.72B |
Dividend Yield | 0.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fortive Corporation Common Stock
Fortive provides industrial and healthcare technology solutions. Its products and software support measurement, maintenance, worker safety, instrument sterilization, and clinical workflows.
Read more on FTV →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
